Genentech - A Member of the Roche Group

Breaking News & Company Info

Get access to Genentech information and resources for stories in development. Find recent and archived press releases.

FDA Approves Genentech Medicine for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives

Learn More

On March 21, 2014, the FDA approved a Genentech medicine for people 12 years of age and older for the treatment of chronic idiopathic urticaria (CIU), a form of chronic hives.

Flu Season 2013: Break the Sick Cycle

On average, 5-20% of the US population gets the flu each year, and more than 200,000 are hospitalized from seasonal flu related complications. To recognize flu symptoms, remember Flu F.A.C.T.S. (Fever, Aches, Chills, (extreme) Tiredness, and Sudden Onset).

View information and materials

gRide Program Achieves Milestone

gRide, Genentech's employee commuting program, has now saved 100 million miles of driving since the program's inception began in late 2006. The program began as a way to reduce the number of vehicles that travel to and park on the South San Francisco campus, and since has had significant impact on Genentech's sustainability goals and employee quality of life.

View information and materials


Load More  

Clinical Trial Data Sharing

As part of our commitment to sharing data from our clinical trials, researchers may now request access to analyzable patient-level data. Learn more.